Tag: COVAXIN

Business

Ocugen Inc (NASDAQ: OCGN) Obtains Producing Collaboration for U.S. Manufacture of COVID-19 Vaccine Entrant, COVAXIN™

Ocugen Inc (NASDAQ: OCGN), a biopharmaceutical business absorbed on discerning, evolving, and commercializing gene treatments to cure and mounting a vaccine to save exists from COVID-19, today proclaimed that it had nominated Jubilant HollisterStier of Spokane, Washington as its assembling companion for COVAXIN™ to concoct for potentially viable assembling of […]

Business

Ocugen Inc. (NASDAQ: OCGN) Will Not Submit EUA for COVAXIN as Indicated Earlier, Shares Plunge

Ocugen Inc. (NASDAQ: OCGN) dropped 24% in intraday trading on June 14, 2021, after national shareholder rights litigation firm, The Schall Law Firm announced that it is probing securities laws violation claims on behalf of Ocugen investors.  Block & Leviton is also investigating the same matter, and investors that lost […]